Excelra (www.excelra.com), a leading data and analytics company, announced the 
successful release of GOBIOM+ (Global Online Biomarker Database), the most 
comprehensive and high-quality biomarker intelligence platform. GOBIOM+ is 
geared to support quick, reliable and data-driven decision making in 
translational drug development. 

To view the Multimedia News Release, please click: 
https://www.multivu.com/players/uk/8522851-excelra-launches-intuitive-avatar/ 

GOBIOM+ [ 
https://www.gobiomdbplus.com/?utm_source=Press%20release&utm_medium=News&utm_campaign=Revamp%20version] 
is a user-centric revamp designed to go from data to insights in an instant. 
The new platform is built on a responsive microservice oriented architecture 
and powered by a state-of-the-art technology stack — the result: enhanced 
functionality that connects biomarker data with analytics and an intuitive user 
experience. 

Some of the novel functionalities include:

- Dedicated modules for Genetic Variants, Pharmacogenomics, Expression 
Profiles, Marker Phenotypes, Approved Diagnostics and Drug Labels 
- Diverse analytical tools such as Comparative Analysis, Heatmap and Cluster 
Analysis, Gene Variant Analysis, Dashboards, and Chromosomal View 
- Comprehensive and structured reports focused on Biomarker, Indication or Drug

The User Interface is designed to help the user interact seamlessly with the 
data to quickly find the specific answers to their questions without the 
distraction of irrelevant information and cumbersome data cleanup. Some of the 
highlights of the interface include:

- User-friendly search and filtering options to query and retrieve precise 
information 
- Presentation-ready visualizations to help derive meaningful insights in a 
flash 
- Online report generation with integrated filtering and search options

Furthermore, the platform provides seamless connectivity with semantic tagging 
and integrated API services that enables the platform to communicate with other 
backend systems. A subscription also includes custom curation and report 
generation services.  

"GOBIOM+ is our flagship database product that scientists and researchers use 
in understanding the biomarker and disease landscape. It is a powerful 
solutioning platform addressing critical questions in the R&D cycle from drug 
discovery to clinical development. We constantly strive to ensure our clients 
have the best experience and this philosophy deeply informs our revamp of the 
product," said Dr. Jesintha Maniraja, Director Biology Services who is also the 
force behind the new GOBIOM+.

Clients leverage GOBIOM+ to:

- Gain insights on Translational, Emerging and Established biomarkers 
- Identify proteins/genes targeted by drugs 
- Select patients who may respond to treatment 
- Identify efficacy biomarkers of drugs for effective designing of clinical 
trials 
- Select Safety biomarkers to understand the toxicity profile of drugs 
- Find biomarkers indicative of disease progression and for monitoring of 
disease 
- Understand the competitive landscape in a given therapeutic area or a 
specific indication 
- Gain insights on probable off-label use of approved drugs in other 
indications 
- Track Preclinical to Clinical translation of a biomarker

About GOBIOM+

GOBIOM+ Biomarker Database is a comprehensive biomarker database that provides 
information on Proteomic, Genomic, Biochemical, Imaging, Metabolite, Clinical 
Scoring scales and Cellular biomarkers for 18 different therapeutic areas, 
covering ~2900 therapeutic indications with its reported utilities like 
diagnosis, prognosis, monitoring disease progression, treatment response, 
surrogate, efficacy and toxicity. Information in GOBIOM+ biomarker database 
gathered from diverse sources, includes clinical trials, scientific 
conferences, regulatory-approved documents and literature databases.

About Excelra: 

Excelra's data and analytics solutions empower innovation in life sciences 
across the value chain from molecule to market. The Excelra Edge comes from a 
seamless amalgamation of data, deep domain expertise and data science. The 
company's multifaceted team helps harmonize large volumes of disparate 
unstructured data; analyze data using cutting-edge AI/ML technologies; and 
galvanize data-driven decisions to unlock operational efficiencies and 
accelerate drug development. Being an end-to-end solution provider, Excelra 
helps break down silos, integrate data and analytics across Omics, Clinical 
Trials, and RWE to uncover novel insights and opportunities. Over the last 17 
years, Excelra has been the preferred data and analytics partner to over 150 
clients including 15 of the top 20 large Pharma companies. To Explore the 
Excelra Edge - visit www.excelra.com

Excelra is hosting a series of webinars to demonstrate how clients can leverage 
the data from GOBIOM+ in the R&D for various indications. One can write to 
marcom@excelra.com to register.

Excelra is headquartered in Hyderabad with offices in Boston, Utrecht, and 
Bangalore. 

For any media query, please reach us at:
Urvi Mehta
Excelra 
urvi.mehta@excelra.com  
M: +91-96526-72200
www.excelra.com

Source: Excelra Knowledge Solutions Pvt. Ltd